Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178834 | SCV000230997 | uncertain significance | not provided | 2018-05-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317051 | SCV000851688 | uncertain significance | Inborn genetic diseases | 2017-05-22 | criteria provided, single submitter | clinical testing | The p.G571S variant (also known as c.1711G>A), located in coding exon 5 of the IQSEC2 gene, results from a G to A substitution at nucleotide position 1711. The glycine at codon 571 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001222587 | SCV001394692 | likely benign | Intellectual disability, X-linked 1 | 2024-08-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178834 | SCV001767334 | likely benign | not provided | 2020-06-22 | criteria provided, single submitter | clinical testing |